Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4CNS 4Sarcoma 3Lymphoid 3Gastrointestinal 2Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Multiple Myeloma 38Lymphoma, Non-Hodgkin 14Hodgkin Disease 13Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia 12Myelodysplastic Syndromes 11Lymphoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Neoplasms, Plasma Cell 10Leukemia, Myeloid, Acute 9Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Hematologic Neoplasms 6Primary Myelofibrosis 4Recurrence 3Myeloproliferative Disorders 3Lymphoma, Follicular 3Leukemia, Plasma Cell 3Leukemia, Myelomonocytic, Chronic 3Graft vs Host Disease 3Anemia, Aplastic 3Polycythemia Vera 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Hematologic Diseases 2Wilms Tumor 1Thrombocytopenia 1Thrombocythemia, Essential 1Testicular Neoplasms 1Smoldering Multiple Myeloma 1

Interventions

sargramostim 2liposomal amphotericin B 2Voriconazole 2Therapeutics 2Polymerase Chain Reaction 2Itraconazole 2Flow Cytometry 2Amplified Fragment Length Polymorphism Analysis 2thymoglobulin 1aldesleukin 1Valacyclovir 1Stem Cell Transplantation 1Rituximab 1Ribavirin 1Radiotherapy 1Proteasome Inhibitors 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Palivizumab 1Monatide (IMS 3015) 1Minocycline 1Methylprednisolone 1Methotrexate 1Lithium Carbonate 1Lithium 1Lenalidomide 1Interleukin-12 Subunit p35 1Interferon-alpha 1Immunomodulating Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Wilms Tumor × Stem Cell Transplantation × Plasma cell × Clear all
NCT00617929 2017-12-28

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
12 enrolled 12 charts
BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Carcinoma, Ovarian Epithelial, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Wilms Tumor, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡